1. Home
  2. GT vs NUVB Comparison

GT vs NUVB Comparison

Compare GT & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Goodyear Tire & Rubber Company

GT

The Goodyear Tire & Rubber Company

HOLD

Current Price

$6.18

Market Cap

1.6B

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$5.32

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GT
NUVB
Founded
1898
2018
Country
United States
United States
Employees
N/A
307
Industry
Automotive Aftermarket
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
GT
NUVB
Price
$6.18
$5.32
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$9.13
$11.38
AVG Volume (30 Days)
8.2M
4.3M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,280,000,000.00
N/A
Revenue This Year
N/A
$203.82
Revenue Next Year
$3.06
$58.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.43
$1.84
52 Week High
$11.65
$9.75

Technical Indicators

Market Signals
Indicator
GT
NUVB
Relative Strength Index (RSI) 49.82 61.24
Support Level $5.43 $5.22
Resistance Level $6.26 $5.34
Average True Range (ATR) 0.26 0.38
MACD 0.09 0.05
Stochastic Oscillator 45.30 72.56

Price Performance

Historical Comparison
GT
NUVB

About GT The Goodyear Tire & Rubber Company

Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific. The majority of its revenue is generated from the Americas business, which develops, manufactures, distributes, and sells tires and related products and services in North, Central, and South America, along with selling tires to various export markets, mainly through intersegment sales.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: